Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
04 August 2015Website:
http://indaptusrx.comNext earnings report:
13 March 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 00:52:13 GMTDividend
Analysts recommendations
Institutional Ownership
INDP Latest News
Preclinical data demonstrates Decoy platform single agent anti-tumor activity and combination-mediated tumor eradication with NSAID, anti-PD1 checkpoint therapy, low dose chemotherapy (LDC) and/or targeted antibody therapy Preclinical data demonstrates Decoy platform single agent anti-tumor activity and combination-mediated tumor eradication with NSAID, anti-PD1 checkpoint therapy, low dose chemotherapy (LDC) and/or targeted antibody therapy
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present at two upcoming investor conferences:
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference. The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.
What type of business is Indaptus Therapeutics?
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
What sector is Indaptus Therapeutics in?
Indaptus Therapeutics is in the Healthcare sector
What industry is Indaptus Therapeutics in?
Indaptus Therapeutics is in the Biotechnology industry
What country is Indaptus Therapeutics from?
Indaptus Therapeutics is headquartered in United States
When did Indaptus Therapeutics go public?
Indaptus Therapeutics initial public offering (IPO) was on 04 August 2015
What is Indaptus Therapeutics website?
https://indaptusrx.com
Is Indaptus Therapeutics in the S&P 500?
No, Indaptus Therapeutics is not included in the S&P 500 index
Is Indaptus Therapeutics in the NASDAQ 100?
No, Indaptus Therapeutics is not included in the NASDAQ 100 index
Is Indaptus Therapeutics in the Dow Jones?
No, Indaptus Therapeutics is not included in the Dow Jones index
When was Indaptus Therapeutics the previous earnings report?
No data
When does Indaptus Therapeutics earnings report?
The next expected earnings date for Indaptus Therapeutics is 13 March 2025